Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil.
Value Health
; 17(7): A641, 2014 Nov.
Article
en En
| MEDLINE
| ID: mdl-27202293
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Health_economic_evaluation
País como asunto:
America do sul
/
Brasil
Idioma:
En
Año:
2014
Tipo del documento:
Article